Dr. Pavel Gris is Chief Scientist of the KEY group of companies and an Adjunct Professor, Department of Chemistry, University of Waterloo. At KEY, Dr. Gris provides member companies of the group’s deuterium and hydrogen divisions with scientific assessments, critical analysis of research activity fundamentals, and deep scientific review of each company’s research and development initiatives. Since joining the KEY group in 2018, his primary focus has been to lead scientific and analytic activities to develop and manufacture deuterated precursors for the pharmaceutical industry as well as deuterated intermediates for the electronics industry. He also evaluates and develops catalyst technology for hydrogen molecule reactions. Within KEY’s deuterium division, Dr. Gris is active in academic collaborations funded by MITACS and Natural Sciences and Engineering Research Council of Canada (NSERC), product and catalyst development, and quality assurance/quality control (QA/QC). He is an active member of the company’s deuterium CMO (contract manufacturing organization) team.
Dr. Gris joined KEY after a career in academia where he obtained extensive experience in a broad range of sciences, clinical research, and university level teaching at Western University, Concordia University, McGill University and University of North Carolina at Chapel Hill. He has a PhD in molecular neurosciences and bioinformatics from the Department of Physiology and Pharmacology at Western University, London, Canada. He has also completed two consecutive post-doctoral appointments at the University of North Carolina in Chapel Hill and McGill University in Montreal. Dr. Gris is a fellow of the Royal Society of Chemistry and a chartered chemist in the province of Ontario.
